LEADER 04281nam  2201177z- 450 
001 9910404084803321
005 20231214133307.0
010   $a3-03928-321-9
035   $a(CKB)4100000011302290
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/46699
035   $a(EXLCZ)994100000011302290
100   $a20202102d2020      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEquine Viruses
210   $cMDPI - Multidisciplinary Digital Publishing Institute$d2020
215   $a1 electronic resource (230 p.)
311   $a3-03928-320-0 
330   $aThe Food and Agriculture Organization of the United Nations has recently estimated that the world equid population exceeds 110 million. Working equids (horses, ponies, donkeys, and mules) remain essential to ensure the livelihood of poor communities around the world. In many developed countries, the equine industry has significant economical weight, with around 7 million horses in Europe alone. The close relationship between humans and equids and the fact that the athlete horse is the terrestrial mammal that travels the most worldwide after humans are important elements to consider in the transmission of pathogens and diseases, amongst equids and to other species. The potential effect of climate change on vector ecology and vector-borne diseases is also of concern for both human and animal health. In this Special Issue, we intend to explore our understanding of a panel of equine viruses, looking at their pathogenicity, their importance in terms of welfare and potential association with diseases, their economic importance and impact on performance, and how their identification can be helped by new technologies and methods.
610   $ahematophagous arthropod
610   $aabortion
610   $ahepacivirus A
610   $aBorna disease virus
610   $avirus transmission
610   $avirus stock propagation
610   $anucleoprotein
610   $ainfluenza A viruses
610   $aequine parvovirus-hepatitis
610   $aneuropathogenic strain
610   $asequencing
610   $aarbovirus
610   $avirome
610   $atransmission
610   $aEquid alphaherpesvirus 1
610   $ainterspecies transmission
610   $arespiratory disease
610   $aoutbreak
610   $aORF34
610   $aORF33
610   $avaccine strategies
610   $aORF30
610   $aflavivirus
610   $ain utero transmission
610   $anon-primate hepacivirus
610   $arisk factors
610   $aAnimal Rule
610   $aequine herpesvirus type 1
610   $aAfrican horse sickness
610   $apolymerase activity
610   $ahorse parvovirus-CSF
610   $ainsects
610   $aequine hepacivirus
610   $ahorse
610   $aParvoviridae
610   $aEquid herpesviruses
610   $aphylogeny
610   $aORF68
610   $avirus structure
610   $aPCR
610   $aGermany
610   $aequine rhinitis virus A
610   $aloss of performance
610   $aELISA
610   $amyeloencephalopathy
610   $astrain selection
610   $aVenezuelan equine encephalitis virus
610   $aequine Mx1
610   $aenteric disease
610   $acDNA cloned virus
610   $afetuses
610   $aEqcopivirus
610   $aequine coronavirus
610   $aIreland
610   $aMxA
610   $agenital wart
610   $aequine papillomaviruses
610   $aequine parvovirus H
610   $areplication
610   $avirus neutralization
610   $aMLST
610   $amosquito-borne virus
610   $aseroprevalence
610   $aequine influenza
610   $arabies
610   $aevolution
610   $aspike S1 protein
610   $ahepatitis
610   $aThoroughbred racehorses
610   $avaccine
610   $abosavirus
610   $aencephalitis
610   $aWest Nile virus
610   $ahorses
700   $aPaillot$b Romain$4auth$01278506
906   $aBOOK
912   $a9910404084803321
996   $aEquine Viruses$93013361
997   $aUNINA